Normalizing Tumor Blood Vessels to Improve Chemotherapy and Inhibit Breast Cancer Metastasis by Multifunctional Nanoparticles.


Journal

Molecular pharmaceutics
ISSN: 1543-8392
Titre abrégé: Mol Pharm
Pays: United States
ID NLM: 101197791

Informations de publication

Date de publication:
02 10 2023
Historique:
medline: 3 10 2023
pubmed: 20 9 2023
entrez: 20 9 2023
Statut: ppublish

Résumé

The abnormal tumor blood vessels with high leakage can promote tumor cells to infiltrate into the systemic circulation and increase the risk of tumor metastasis. In addition, chemotherapy may destroy tumor blood vessels and further aggravate metastasis. Normalizing tumor blood vessels can reduce vascular leakage and increase vascular integrity. The simultaneous administration of vascular normalization drugs and chemotherapy drugs may resist the blood vessels' destruction of chemotherapy. Here, multifunctional nanoparticles (CCM@LMSN/DOX&St), which combined chemotherapy with tumor blood vessel normalization, were prepared for the treatment of breast cancer. The results showed that CCM@LMSN/DOX&St-loaded sunitinib (St) promoted the expression of junction proteins Claudin-4 and VE-cadherin of endothelial cells, reversed the destruction of DOX to the endothelial cell layer, protected the integrity of the endothelial cell layer, and inhibited the migration of 4T1 tumor cells across the endothelial cell layer.

Identifiants

pubmed: 37728215
doi: 10.1021/acs.molpharmaceut.3c00381
doi:

Substances chimiques

Doxorubicin 80168379AG

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

5078-5089

Auteurs

Yingping Zeng (Y)

College of Pharmaceutical Science, Zhejiang University, Hangzhou 310058, China.

Shufen Zhang (S)

College of Pharmaceutical Science, Zhejiang University, Hangzhou 310058, China.

Sufen Li (S)

College of Pharmaceutical Science, Zhejiang University, Hangzhou 310058, China.

Guangtao Song (G)

College of Pharmaceutical Science, Zhejiang University, Hangzhou 310058, China.

Tingting Meng (T)

College of Pharmaceutical Science, Zhejiang University, Hangzhou 310058, China.

Hong Yuan (H)

College of Pharmaceutical Science, Zhejiang University, Hangzhou 310058, China.
Jinhua Institute of Zhejiang University, Jinhua 321299, China.

Fuqiang Hu (F)

College of Pharmaceutical Science, Zhejiang University, Hangzhou 310058, China.
Jinhua Institute of Zhejiang University, Jinhua 321299, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH